Institutes
Refine
Document Type
- Article (15)
Language
- English (15)
Has Fulltext
- yes (15)
Is part of the Bibliography
- no (15)
Keywords
- SARS-CoV-2 (9)
- COVID19-NMR (4)
- Non-structural protein (3)
- RNA (3)
- Solution NMR spectroscopy (3)
- Solution NMR-spectroscopy (3)
- 5′-UTR (2)
- Covid19-NMR (2)
- NMR spectroscopy (2)
- Protein drugability (2)
- 19F (1)
- 2D NMR spectroscopy (1)
- 5'-UTR (1)
- CEST (1)
- COVID-19 (1)
- Covid19-nmr (1)
- DNA-PAINT (1)
- Drug discovery (1)
- FBDD (1)
- FBS (1)
- Fragment (1)
- G-quadruplexes (1)
- Ligands (1)
- Macrodomain (1)
- Mycobacterium tuberculosis (1)
- NMR (1)
- NOESY (1)
- Nucleic acid-binding domain (1)
- Quality control (1)
- SL1 (1)
- SL5a (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- Solubility (1)
- TERRA RNA (1)
- accessory proteins (1)
- cell-free protein synthesis (1)
- cysteine-redox regulation (1)
- fluorine (1)
- folding landscapes (1)
- fragment screening (1)
- fragment-based screening (1)
- intrinsically disordered region (1)
- kinetics (1)
- nonstructural proteins (1)
- nuclear magnetic resonance spectroscopy (1)
- protein oxidation (1)
- protein tyrosine phosphatase (1)
- proteins (1)
- reactive oxygen species (1)
- real-time NMR spectroscopy (1)
- structural proteins (1)
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.